← Back to Search

Guided Imagery for Head and Neck Cancer

N/A

Waitlist Available

Led By Elissa Kolva

Research Sponsored by University of Colorado, Denver

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Aged 18 - 100

Confirmed malignancy of the head and neck region (including metastases from other primary tumors and cancers of unknown primary)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up from baseline to one month post-radiotherapy, up to 12 weeks.

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to test if using guided imagery can help reduce anxiety and depression in head and neck cancer patients undergoing radiotherapy.

Who is the study for?

This trial is for adults aged 18-100 with confirmed head and neck cancer, including metastases from other tumors. Participants must be able to read and communicate in English, have no unmanaged psychiatric symptoms or dementia, and be starting radiotherapy at the University of Colorado Cancer Center. They need internet or phone access for remote meetings.

What is being tested?

The study tests whether guided imagery can help reduce anxiety and depression related to radiotherapy in patients with head and neck cancers compared to usual treatment without this intervention. It's a pilot study focusing on feasibility, acceptability, and initial effectiveness.

What are the potential side effects?

Since the intervention involves guided imagery—a relaxation technique—side effects are minimal but may include discomfort or emotional distress if participants find revisiting certain thoughts challenging during sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 100 years old.

Select...

My cancer is in the head or neck area, or it spread there from another place.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ from baseline to one month post-radiotherapy.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~from baseline to one month post-radiotherapy.

This trial's timeline: 3 weeks for screening, Varies for treatment, and from baseline to one month post-radiotherapy. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

The Amount of Patients Who Find Using Guided Imagery Beneficial as a Form of Treatment While Undergoing Radiotherapy: [Acceptability]

The Desire for Patients to Want to Use Guided Imagery While Undergoing Radiotherapy: [Feasibility]

Secondary study objectives

Change From Baseline in Hospital Anxiety and Depression Scales (HADS) Score

Change From Baseline in Memorial Symptom Assessment Scale Short Form (MSAS-SF) Score

The Effect Guided Imagery Has on Distress While Undergoing Radiotherapy: [Impact]

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Guided ImageryExperimental Treatment1 Intervention

The GI intervention will include direct, written, and audio delivery of one of three GI vignettes (depiction).The patient will be able to choose one of the three vignettes.

Group II: Treatment as UsualActive Control1 Intervention

The control, or treatment as usual condition, will include an orientation to radiotherapy from the clinic nurse coordinator.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Guided Imagery

2010

N/A

~960

0 / 2Eligibility criteria met